Total Payments
$971.27
2024 Payments
$85.41
Companies
13
Transactions
24
Medicare Patients
2,611
Medicare Billing
$306,877
Payment Breakdown by Category
Food & Beverage$971.27 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $971.27 | 24 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $198.80 | 4 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $132.65 | 3 | $0 (2018) |
| Mallinckrodt LLC | $120.47 | 1 | $0 (2017) |
| The Medicines Company | $116.16 | 7 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $99.39 | 1 | $0 (2017) |
| ABIOMED | $85.41 | 1 | $0 (2024) |
| Philips Electronics North America Corporation | $79.50 | 1 | $0 (2018) |
| Relypsa, Inc. | $63.25 | 1 | $0 (2017) |
| RARE DISEASE THERAPEUTICS, INC. | $19.58 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $15.67 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $85.41 | 1 | ABIOMED ($85.41) |
| 2023 | $62.48 | 4 | RARE DISEASE THERAPEUTICS, INC. ($19.58) |
| 2022 | $11.68 | 1 | AstraZeneca Pharmaceuticals LP ($11.68) |
| 2021 | $15.67 | 1 | Alexion Pharmaceuticals, Inc. ($15.67) |
| 2020 | $120.38 | 1 | Janssen Pharmaceuticals, Inc ($120.38) |
| 2019 | $11.24 | 1 | Janssen Pharmaceuticals, Inc ($11.24) |
| 2018 | $194.23 | 3 | Philips Electronics North America Corporation ($79.50) |
| 2017 | $470.18 | 12 | Mallinckrodt LLC ($120.47) |
All Payment Transactions
24 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/24/2024 | ABIOMED | Impella (Device) | Food and Beverage | Cash or cash equivalent | $85.41 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/01/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | RELISTOR (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Gastroenterology | ||||||
| 10/20/2023 | Urgo Medical North America, LLC | URGOK2 (Device), VASHE WOUND SOLUTION 250 ML (8.5 FL OZ) FLIP TOP CAP | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: COMPRESSION | ||||||
| 06/17/2023 | RARE DISEASE THERAPEUTICS, INC. | Anavip (Biological) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: Antivenin | ||||||
| 04/28/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.19 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/19/2022 | AstraZeneca Pharmaceuticals LP | ANDEXXA (Biological) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: Rare Disease | ||||||
| 02/18/2021 | Alexion Pharmaceuticals, Inc. | Andexxa (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: Hematology | ||||||
| 03/05/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $120.38 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/17/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $11.24 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/10/2018 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $52.99 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/12/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $61.74 | General |
| Category: Cardiovascular | ||||||
| 02/08/2018 | Philips Electronics North America Corporation | IGT_D Peripheral (Device) | Food and Beverage | Cash or cash equivalent | $79.50 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/07/2017 | The Medicines Company | ORBACTIV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $1.13 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/03/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $1.45 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/12/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.42 | General |
| Category: Cardiovascular | ||||||
| 10/11/2017 | Valeant Pharmaceuticals North America LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $99.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/11/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $12.23 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 08/09/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $2.99 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/13/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $58.49 | General |
| Category: Cardiovascular | ||||||
| 06/08/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $4.34 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 05/10/2017 | Relypsa, Inc. | Veltassa (Drug) | Food and Beverage | In-kind items and services | $63.25 | General |
| Category: Hyperkalemia | ||||||
| 04/12/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $93.74 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/28/2017 | The Medicines Company | MINOCIN IV (Drug), ORBACTIV | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 01/11/2017 | Mallinckrodt LLC | OFIRMEV (Drug) | Food and Beverage | In-kind items and services | $120.47 | General |
| Category: ACUTE CARE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 668 | 690 | $462,400 | $80,254 |
| 2022 | 5 | 576 | 584 | $373,567 | $67,436 |
| 2021 | 5 | 689 | 709 | $448,929 | $80,654 |
| 2020 | 4 | 678 | 695 | $463,017 | $78,534 |
Total Patients
2,611
Total Services
2,678
Medicare Billing
$306,877
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 257 | 268 | $165,892 | $35,627 | 21.5% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 251 | 257 | $141,350 | $23,001 | 16.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 113 | 118 | $135,700 | $19,318 | 14.2% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 47 | 47 | $19,458 | $2,308 | 11.9% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 218 | 224 | $138,587 | $31,119 | 22.5% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 174 | 175 | $96,250 | $16,033 | 16.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 87 | 88 | $101,200 | $15,731 | 15.5% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 79 | 79 | $32,706 | $3,986 | 12.2% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 18 | 18 | $4,824 | $566.38 | 11.7% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 233 | 242 | $136,619 | $34,086 | 24.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 236 | 243 | $146,622 | $22,059 | 15.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 100 | 102 | $117,224 | $18,343 | 15.6% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 106 | 108 | $44,712 | $5,702 | 12.8% |
| 99282 | Emergency department visit, low to moderately severe problem | Facility | 2021 | 14 | 14 | $3,752 | $464.66 | 12.4% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 266 | 273 | $151,350 | $35,354 | 23.4% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 132 | 134 | $154,100 | $22,076 | 14.3% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 181 | 187 | $115,753 | $16,323 | 14.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 99 | 101 | $41,814 | $4,780 | 11.4% |
About Dr. Mallory Blakeslee, D.O
Dr. Mallory Blakeslee, D.O is a Emergency Medicine healthcare provider based in Gulfport, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/22/2014. The National Provider Identifier (NPI) number assigned to this provider is 1932516945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mallory Blakeslee, D.O has received a total of $971.27 in payments from pharmaceutical and medical device companies, with $85.41 received in 2024. These payments were reported across 24 transactions from 13 companies. The most common payment nature is "Food and Beverage" ($971.27).
As a Medicare-enrolled provider, Blakeslee has provided services to 2,611 Medicare beneficiaries, totaling 2,678 services with total Medicare billing of $306,877. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medicine
- Other Specialties Emergency Medicine
- Location Gulfport, MS
- Active Since 07/22/2014
- Last Updated 04/08/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1932516945
Products in Payments
- XARELTO (Drug) $198.80
- ELIQUIS (Drug) $132.65
- OFIRMEV (Drug) $120.47
- MINOCIN IV (Drug) $115.03
- XIFAXAN (Drug) $99.39
- Impella (Device) $85.41
- IGT_D Peripheral (Device) $79.50
- Veltassa (Drug) $63.25
- Anavip (Biological) $19.58
- Andexxa (Drug) $15.67
- RELISTOR (Drug) $15.42
- URGOK2 (Device) $13.29
- ANDEXXA (Biological) $11.68
- ORBACTIV (Drug) $1.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Gulfport
Dr. Ronnie Ali, Do, DO
Emergency Medicine — Payments: $3,700
Emergency Medicine $3,700
Dr. Drew Weber, M.d, M.D
Emergency Medicine — Payments: $745.89
Emergency Medicine $745.89
Joshua Thomas, M.d, M.D
Emergency Medicine — Payments: $267.26
Emergency Medicine $267.26
Larry Couvillon, M.d, M.D
Emergency Medicine — Payments: $262.96
Emergency Medicine $262.96
Carol Smith, M.d, M.D
Emergency Medicine — Payments: $230.74
Emergency Medicine $230.74
Dr. Andrew Nakamoto, M.d, M.D
Emergency Medicine — Payments: $228.21
Emergency Medicine $228.21